| 标题 |
Randomized phase II study of nimotuzumab, an anti-EGFR antibody, plus irinotecan in patients with 5-fluorouracil–based regimen-refractory advanced or recurrent gastric cancer in Korea and Japan: Preliminary results |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:Y. H. Kim; Y. Sasaki; K. H. Lee; S. Y. Rha; S. Park; et al 出版日期:2017-02-24 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)